Benitec Biopharma Dirección
Dirección controles de criterios 2/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Jerel Banks
Chief Executive Officer (CEO)
US$2.8m
Compensación total
| Porcentaje del salario del CEO | 22.4% |
| Permanencia del CEO | 6.4yrs |
| Participación del CEO | n/a |
| Permanencia media de la dirección | 6.4yrs |
| Promedio de permanencia en la Junta Directiva | 9.1yrs |
Actualizaciones recientes de la dirección
Recent updates
Companies Like Benitec Biopharma (NASDAQ:BNTC) Are In A Position To Invest In Growth
Oct 02
Most Shareholders Will Probably Find That The Compensation For Benitec Biopharma Inc.'s (NASDAQ:BNTC) CEO Is Reasonable
Nov 30Benitec Biopharma prices of $18M securities offering
Sep 13Benitec GAAP EPS of -$2.23, revenue of $0.07M
Sep 02We're A Little Worried About Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Rate
Jan 13We Think Benitec Biopharma (NASDAQ:BNTC) Needs To Drive Business Growth Carefully
Sep 30Will Benitec Biopharma (NASDAQ:BNTC) Spend Its Cash Wisely?
May 12Benitec Bio secures $13M capital via equity offering
Apr 28Can Benitec Biopharma (NASDAQ:BNTC) Afford To Invest In Growth?
Jan 27How Does Benitec Biopharma's (NASDAQ:BNTC) CEO Salary Compare to Peers?
Dec 02Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jun 30 2024 | US$3m | US$628k | -US$22m |
| Mar 31 2024 | n/a | n/a | -US$22m |
| Dec 31 2023 | n/a | n/a | -US$22m |
| Sep 30 2023 | n/a | n/a | -US$20m |
| Jun 30 2023 | US$919k | US$540k | -US$20m |
| Mar 31 2023 | n/a | n/a | -US$20m |
| Dec 31 2022 | n/a | n/a | -US$19m |
| Sep 30 2022 | n/a | n/a | -US$18m |
| Jun 30 2022 | US$800k | US$506k | -US$18m |
| Mar 31 2022 | n/a | n/a | -US$17m |
| Dec 31 2021 | n/a | n/a | -US$18m |
| Sep 30 2021 | n/a | n/a | -US$16m |
| Jun 30 2021 | US$1m | US$440k | -US$14m |
| Mar 31 2021 | n/a | n/a | -US$13m |
| Dec 31 2020 | n/a | n/a | -US$11m |
| Sep 30 2020 | n/a | n/a | -US$10m |
| Jun 30 2020 | US$632k | US$400k | -US$8m |
| Mar 31 2020 | n/a | n/a | -US$7m |
| Dec 31 2019 | n/a | n/a | -US$6m |
| Sep 30 2019 | n/a | n/a | -US$2m |
| Jun 30 2019 | US$615k | US$400k | US$3m |
| Mar 31 2019 | n/a | n/a | US$2m |
| Dec 31 2018 | n/a | n/a | US$2m |
| Sep 30 2018 | n/a | n/a | -US$3m |
| Jun 30 2018 | US$91k | n/a | -US$9m |
Compensación vs. Mercado: La compensación total de Jerel($USD2.80M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD1.48M).
Compensación vs. Ingresos: La compensación de Jerel ha aumentado mientras la empresa no es rentable.
CEO
Jerel Banks (49 yo)
6.4yrs
Permanencia
US$2,798,977
Compensación
Dr. Jerel A. Banks, Ph D., M.D., has been the Chief Executive Officer of Benitec Biopharma Inc. since June 26, 2018. Dr. Banks has been the Executive Chairman of the Board at Benitec Biopharma Inc. since O...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman & CEO | 6.4yrs | US$2.80m | sin datos | |
| Executive Director | 6.4yrs | US$1.28m | 0.13% $ 283.1k | |
| Head of Discovery & Founding Scientist | 9.4yrs | US$231.48k | sin datos | |
| Senior Vice President of Manufacturing | no data | sin datos | sin datos |
6.4yrs
Permanencia media
Equipo directivo experimentado: El equipo directivo de BNTC es experimentado (6.4 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman & CEO | 8.1yrs | US$2.80m | sin datos | |
| Executive Director | 8.3yrs | US$1.28m | 0.13% $ 283.1k | |
| Independent Non-Executive Director | 11.6yrs | US$159.97k | 0.26% $ 568.9k | |
| Independent Non-Executive Director | 18.8yrs | US$154.51k | 0.000090% $ 194.7 | |
| Independent Non-Executive Director | 4.6yrs | US$152.47k | 0% $ 0 | |
| Director | less than a year | sin datos | sin datos | |
| Member of Hepatology Clinical Advisory Board | 9.1yrs | sin datos | sin datos | |
| Member of Hepatology Clinical Advisory Board | 9.1yrs | sin datos | sin datos | |
| Member of Hepatology Clinical Advisory Board | 9.1yrs | sin datos | sin datos | |
| Member of Scientific & Clinical Advisory Board | no data | sin datos | sin datos |
9.1yrs
Permanencia media
52.5yo
Promedio de edad
Junta con experiencia: La junta directiva de BNTC se considera experimentada (9.1 años de antigüedad promedio).